πŸ‡¦πŸ‡ΊπŸ‡¨πŸ‡¦Lab Head @MonashBDI @VicHeartInst|Director @atheroaussie| Atherosclerosis,Obesity,macrophage inflammation| #macrophage_yogi|#positive_mentor| my opinion

Melbourne, Victoria, Australia
Joined January 2014
πŸ‘‡πŸ½Research @NatMetabolism rdcu.be/b7N6d An inflammatory gene, RIPK1, increases obesity risk. Our follow-up intervention study @IMBatUQ also shows promise...watch this space for more updates! πŸ‘πŸ½ #obesity #genetics #RIPK1 #inflammation @UQ_News @HeartInstitute
A Queensland scientist is leading a world study that uncovered an inflammatory gene responsible for obesity. Blocking the gene could stop weight loss in its tracks, helping millions of Australians. 7NEWS.com.au @BrittanyCLane #7NEWS
1
1
13
Denuja Karunakaran, PhD πŸ‘©πŸ½β€πŸ”¬πŸ”¬πŸ§¬πŸ«€ retweeted
Macrophages can engulf targets whole (phagocytosis) or nibble them in small fragments (trogocytosis), a decision controlled by cortical tension in the targets (high tension favors former, low latter) nature.com/articles/s41556-0… nature.com/articles/s41556-0… @NatureCellBio @UCBerkeley
1
46
3
167
9,650
Denuja Karunakaran, PhD πŸ‘©πŸ½β€πŸ”¬πŸ”¬πŸ§¬πŸ«€ retweeted
What if the future of treating heart disease could be a 'one-and-done' therapy? A first in human gene-editing study, led by @ProfSNicholls, showed a reduction in LDL by up to 50% and triglycerides by 55% - with a single infusion. πŸŽ₯ Watch @AHAScience tv: lnkd.in/g5h2Pv3w
1
126
Denuja Karunakaran, PhD πŸ‘©πŸ½β€πŸ”¬πŸ”¬πŸ§¬πŸ«€ retweeted
🚨 Our new publication in Nature Communications!
 Macrophage WDFY3 protects against autoimmunity by boosting efferocytosis and dampening T cell activation.
 πŸ›‘οΈ A safeguard for immune homeostasis. nature.com/articles/s41467-0…
3
3
1
14
1,660
Denuja Karunakaran, PhD πŸ‘©πŸ½β€πŸ”¬πŸ”¬πŸ§¬πŸ«€ retweeted
Abstract submission is open for our annual scientific meeting! Submit via: app.oxfordabstracts.com/stag…
1
2
154
Great writing tips for students #positive_mentor
12 lessons students learn in the Sinclair Lab: Lesson 1. Write the way you speak
148
Denuja Karunakaran, PhD πŸ‘©πŸ½β€πŸ”¬πŸ”¬πŸ§¬πŸ«€ retweeted
Reminder that our obsession with journal names as a lazy proxy for "impact" is new. Here are the key papers that led to the GLP-1 Lasker Award for Svetlana Mojsov: Mojsov et al JBC 261:11880 1986 Mojsov et al JCI 79:616 1987 Mojsov et al JBC 265:8001 1990 Journal of Biological Chemistry Journal of Clinical Investigation
1
16
2
77
12,407
Denuja Karunakaran, PhD πŸ‘©πŸ½β€πŸ”¬πŸ”¬πŸ§¬πŸ«€ retweeted
How long it takes...
2
211
14
1,426
109,827
Denuja Karunakaran, PhD πŸ‘©πŸ½β€πŸ”¬πŸ”¬πŸ§¬πŸ«€ retweeted
In 1928, Alexander Fleming discovered the mould he was working with produced a substance that could kill many common bacteria. He called this new, exciting substance "mould juice". Only after a couple of months did he name it penicillin. #WorldAntibioticAwarenessWeek
4
81
11
330
26,825
Denuja Karunakaran, PhD πŸ‘©πŸ½β€πŸ”¬πŸ”¬πŸ§¬πŸ«€ retweeted
Victorian Heart Institute and Hospital Director @ProfSNicholls is leading world-first trials for genetic high cholesterol, expanding potentially life-saving treatments for those at risk of heart attack and stroke, presented at @American_Heart. Read: bit.ly/3Zf4IyK
1
3
20
780
Denuja Karunakaran, PhD πŸ‘©πŸ½β€πŸ”¬πŸ”¬πŸ§¬πŸ«€ retweeted
Day 2 at @BDI_MDOP #MDO2024 and we have @denujak from @MonashVHI presenting her work on the therapeutic knockdown of the RIPK1 pathway to reduce diet-induced obesity and improve insulin sensitivity πŸ€©πŸ‘πŸΌ
2
3
293
True purpose - β€˜what’s next? What can I do?”
Demoted four times and threatened with deportation, 2023 medicine laureate Katalin KarikΓ³'s journey in science was difficult but she persevered: "You have to channel all your energy into seeking out 'What's next? What can I do?'" Listen to her interview: bit.ly/3FcYzbp
124
Well done @emma_solly!! Very well deserved! An excellent talk! πŸ‘πŸ½πŸ‘πŸ½πŸ‘πŸ½Must be a proud supervisor @jotan80 ❀️
The ECR Rising Star Award Winner at the #AASASM24 was Dr Emma Solly. Congratulations on a fantastic contribution and exciting data. Thanks to CSL for sponsoring our Rising Stars.🌟
1
3
181
Denuja Karunakaran, PhD πŸ‘©πŸ½β€πŸ”¬πŸ”¬πŸ§¬πŸ«€ retweeted
Our Director & CEO, Prof Elizabeth Hartland AM is among an impressive group of health & medical leaders named Fellows of the Australian Academy of Health & Medical Sciences. Congratulations @ProfHartland! πŸ₯³ #AAHMSFellow @AAHMS_health Read more here: bit.ly/3YiCuRZ
#AAHMSFellow @Hudson_Research CEO @ProfHartland Professor Elizabeth Hartland's internationally recognised research informs fundamental knowledge of host-pathogen interactions and the development of anti-infective and immune-enhancing therapies that target the infection process.
2
2
1
34
3,128
Denuja Karunakaran, PhD πŸ‘©πŸ½β€πŸ”¬πŸ”¬πŸ§¬πŸ«€ retweeted
Huge congratulations to our Scientific Head, Prof James Whisstock, on his election as an #AAHMS Fellow for his contributions to the field of #immunology & beyond!
Prof James Whisstock’s discoveries include elucidating the mechanism of function of perforin-like proteins and using his discoveries to develop new immunotherapeutics. #AAHMSFellow @Monash_FMNHS
3
7
879
#proudPI. My Postdoc presented some exciting work within 3 mths of starting! Very exciting times. Congrats Narmadaa at being an AAS ECR Finalist @MonashVHI @MonashBDI
One of the highlights of the meeting is always seeing our Rising Stars shine and this morning it was the ECRs who did the shining! Dr Dragana Dragoljevic, Dr Emma Solly, Dr Jordyn Thomas & Dr Narmadaa Thyagarajan.
1
205
Denuja Karunakaran, PhD πŸ‘©πŸ½β€πŸ”¬πŸ”¬πŸ§¬πŸ«€ retweeted
Fantastic talk on TRAIL by Dr Sian Cartland from ⁦@KavurmaMary’s group⁩! There’s still so much we don’t know. Also, congratulations to Dr Cartland who’s a new Group Leader ⁦@HRIAust⁩ πŸ‘πŸ½πŸ‘πŸ½πŸ‘πŸ½
1
1
6
454
PhD student Han Xu delivered a great flask talk on RIPK1 in macrophages and regulation of inflammation. @denujak
1
117
Very exciting and interesting talk @KerryRye @atheroaussie! #T1D #atherosclerosis
Our first national plenary was delivered by long time AAS member and lipoprotein expert, Prof Kerry-Anne Rye who talks us through their recent data in therapeutic options to reduce cardiometabolic disease.
114
Denuja Karunakaran, PhD πŸ‘©πŸ½β€πŸ”¬πŸ”¬πŸ§¬πŸ«€ retweeted
Our first national plenary was delivered by long time AAS member and lipoprotein expert, Prof Kerry-Anne Rye who talks us through their recent data in therapeutic options to reduce cardiometabolic disease.
1
1
3
250
And it’s official! ⁦@atheroaussie⁩ annual scientific meeting has launched! A warm welcome by our current President ⁦⁦@Judy_deHaan29⁩! 50 years of celebrations has begun ⁦@atheroaussie⁩
1
94